Prime Medicine (PRME) Shares Issued (2022 - 2026)

Prime Medicine has reported Shares Issued for 5 years, with the latest figure at $393000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $393000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 96.82% YoY), and the FY2025 full-year result was $781000.0, down 97.95% from the prior year.
• Shares Issued for Q1 2026 stood at $393000.0, down from $781000.0 in the prior quarter.
• The five-year high for Shares Issued was $185.3 million in Q4 2022, with the low at -$1.1 million in Q2 2024.
• Historically, Shares Issued has averaged $22.5 million across 5 years, with a median of $427000.0 in 2023.
• Annual changes were most pronounced in 2023 — Shares Issued tumbled 100.25% — and 2024, when it jumped 8338.18%.
• Prime Medicine's Shares Issued stood at $185.3 million in 2022, then plunged by 100.25% to -$461000.0 in 2023, then jumped by 8338.18% to $38.0 million in 2024, then sank by 97.94% to $781000.0 in 2025, then slumped by 49.68% to $393000.0 in 2026.
• The last three Shares Issued figures came in at $393000.0 (Q1 2026), $781000.0 (Q4 2025), and $38.0 million (Q4 2024), per Business Quant data.